Discover
AZN
AstraZeneca PLC
159.59
1 x 159.60
1 x 159.63
bid
ask
-
2.31
1.43%
12:36 PM
timesize
| Ytd | -13.20% | |
| 1y | 7.73% |
159.41
day range
162.26
147.06
52 week range
209.48
| Open | 161.93 | Prev Close | 161.91 | Low | 159.41 | High | 162.26 | Mkt Cap | 247.53B |
| Vol | 1.59M | Avg Vol | 2.72M | EPS | 9.26 | P/E | 17.24 | Forward P/E | 13.94 |
| Beta | 0.26 | Short Ratio | 1.00 | Inst. Own | 64.56% | Dividend | 4.34 | Div Yield | 2.69 |
| Ex Div Date | 08-07 | Earning | 07-27 | 50-d Avg | 175.90 | 200-d Avg | 184.54 | 1yr Est | 213.69 |
| Income Statement | |||
| Total Revenue | 15.38B | ||
| Revenues (USD) | 15.38B | ||
| Cost of Revenue | 2.52B | ||
| Gross Profit | 12.86B | ||
| Operating Expenses | 9.70B | ||
| Research and Development Expense | 4.05B | ||
| Selling, General and Administrative Expense | 5.80B | ||
| Operating Income | 3.16B | ||
| Interest Expense | 435.00M | ||
| Income Tax Expense | 291.00M | ||
| Net Income | 2.51B | ||
| Net Income Common Stock | 2.51B | ||
| Net Income Common Stock (USD) | 2.51B | ||
| Consolidated Income | 2.51B | ||
| Net Income to Non-Controlling Interests | 1000.00K | ||
| Earnings per Basic Share | 1.61 | ||
| Earnings per Basic Share (USD) | 1.61 | ||
| Earnings per Diluted Share | 1.61 | ||
| Earning Before Interest & Taxes (EBIT) | 3.23B | ||
| Earning Before Interest & Taxes (USD) | 3.23B | ||
| Weighted Average Shares | 1.55B | ||
| Weighted Average Shares Diluted | 1.56B | ||
| Balance Sheet | |||
| Cash and Equivalents | 4.89B | ||
| Cash and Equivalents (USD) | 4.89B | ||
| Investments | 2.99B | ||
| Investments Current | 75.00M | ||
| Investments Non-Current | 2.92B | ||
| Trade and Non-Trade Receivables | 15.68B | ||
| Current Assets | 27.97B | ||
| Property, Plant & Equipment Net | 16.30B | ||
| Total Assets | 115.83B | ||
| Debt Current | 6.23B | ||
| Total Debt | 32.24B | ||
| Current Liabilities | 31.55B | ||
| Debt Non-Current | 26.01B | ||
| Total Liabilities | 65.46B | ||
| Accumulated Retained Earnings (Deficit) | 12.59B | ||
| Shareholders Equity | 50.30B | ||
| Shareholders Equity (USD) | 50.30B | ||
| Assets Non-Current | 87.87B | ||
| Total Debt (USD) | 32.24B | ||
| Goodwill and Intangible Assets | 58.90B | ||
| Inventory | 6.93B | ||
| Liabilities Non-Current | 33.91B | ||
| Trade and Non-Trade Payables | 24.86B | ||
| Tax Assets | 9.66B | ||
| Tax Liabilities | 5.58B | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.93B | ||
| Net Cash Flow from Financing | -2.59B | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -2.64B | ||
| Capital Expenditure | -759.00M | ||
| Net Cash Flow - Business Acquisitions and Disposals | -33.00M | ||
| Issuance (Purchase) of Equity Shares | -40.00M | ||
| Issuance (Repayment) of Debt Securities | -2.55B | ||
| Payment of Dividends & Other Cash Distributions | -1000.00K | ||
| Net Cash Flow from Investing | -2.91B | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 40.00M | ||
| Net Cash Flow from Operations | 2.87B | ||
| Effect of Exchange Rate Changes on Cash | 9.00M | ||